Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
08/26/2009 | CN100532364C 5-substituted-alkylaminopyrazole derivatives as pesticides |
08/25/2009 | US7579476 Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals |
08/25/2009 | US7579469 For therapy of disease characterized by inflammatory, allergic, or proliferative processes |
08/25/2009 | US7579467 N-phenyl-2-pyrimidine-amine derivatives |
08/25/2009 | US7579465 For treatment of picornavirus infections in mammals |
08/25/2009 | US7579411 Process for the controlled increase in the molecular weight of polyethylenes |
08/25/2009 | US7579369 CB 1 receptor inverse agonists |
08/25/2009 | US7579365 For therapy of oncoses |
08/25/2009 | US7579363 Bicyclic compounds and compositions as PDF inhibitors |
08/25/2009 | US7579362 3-(6-p-Tolyl-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane; treatment of psychotic disorders such as schizophrenia, mania, depression and anxiety; neurodegenerataive disorders such as senile dementia, Alzhelmer's disease and other intellectual impairment disorders |
08/25/2009 | US7579357 Antidiabetic agents; obesity; controlling appetite |
08/25/2009 | US7579355 Inhibitors of Akt activity |
08/25/2009 | US7579353 5-Bromo-2,6-dimethyl-6'-{[4-(trifluoromethoxy)benzyl]oxy}-3,3'-bipyridin-4(1H)-one; 3-Chloro-2,6-dimethyl-5-(5-nonyl-2-pyrimidinyl)-4(1H)-pyridinone; treating maleria causerd by infection with Plasmodium falciparum |
08/25/2009 | US7579352 Retinoic acid mimetic anilides |
08/25/2009 | US7579347 Vanilloid receptor ligands and their use in treatments |
08/25/2009 | US7579341 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions |
08/25/2009 | US7579091 White electroluminescent polymeric material and preparation thereof |
08/25/2009 | CA2538072C Amide-type carboxamide derivatives |
08/25/2009 | CA2505086C Ophthalmic compositions for treating ocular hypertension |
08/25/2009 | CA2474578C Novel pyridin- and pyrimidin-derivatives |
08/25/2009 | CA2383466C Aromatic nitrogen-containing 6-membered cyclic compounds |
08/25/2009 | CA2375671C 4-phenyl-pyrimidine derivatives |
08/25/2009 | CA2327673C Aminopiperidine derivatives as integrin .alpha.v.beta.3 antagonists |
08/25/2009 | CA2326815C Process for preparation of pyridine derivatives |
08/25/2009 | CA2269246C Substituted tricyclics |
08/20/2009 | WO2009103007A2 Steroid hormone receptor modulator compounds and methods |
08/20/2009 | WO2009102155A2 Process for preparation of 2-methyl-2´-phenylpropionic acid derivatives and novel intermediate compounds |
08/20/2009 | WO2009101082A1 Substituted sulfonic acid amide compounds |
08/20/2009 | WO2009101079A1 Pyrimidylmethyl sulfonamide compounds |
08/20/2009 | WO2009101078A1 Pyrimidylmethyl sulfonamide compounds |
08/20/2009 | WO2009100994A1 Piperidine sulfonamide derivatives |
08/20/2009 | WO2009100872A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
08/20/2009 | WO2009100827A1 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and use thereof |
08/20/2009 | WO2009100592A1 Preparation of rupatadine or it's salts |
08/20/2009 | WO2009081105A3 Quinoxaline and quinoline derivatives as kinase inhibitors |
08/20/2009 | WO2009074749A3 Nicotinamide derivatives, preparation thereof and therapeutic use thereof |
08/20/2009 | WO2009037244A3 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists |
08/20/2009 | US20090209759 Automated iterative drug discovery and synthesis |
08/20/2009 | US20090209598 Resorcine Derivatives and Their Use as Pesticides |
08/20/2009 | US20090209597 Imidazole derivatives and their use for modulating the gaba alpha receptor complex |
08/20/2009 | US20090209595 Method of treating of demyelinating diseases or conditions |
08/20/2009 | US20090209594 Method of treating of demyelinating diseases or conditions |
08/20/2009 | US20090209592 Inhibitors of the gastric h+, k+-atpase with enhanced therapeutic properties |
08/20/2009 | US20090209589 N-[(pyridin-2-yl) methoxy] hetrocyclyl carboxamide derivatives and related compounds as fungicides |
08/20/2009 | US20090209588 Novel compounds, their preparation and use |
08/20/2009 | US20090209582 Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
08/20/2009 | US20090209578 Chemical compounds |
08/20/2009 | US20090209563 Pyridinoylpiperidines as 5-HT1F agonists |
08/20/2009 | US20090209562 Fused ring 4-oxopyrimidine derivative |
08/20/2009 | US20090209556 Soluble guanylate cyclase activators |
08/20/2009 | US20090209552 Organic Compounds |
08/20/2009 | US20090209550 Substituted triazolopyridines |
08/20/2009 | US20090209542 mitogen activated protein kinase inhibitors; 4-(2-Fluoro-4-(methylthio)phenylamino)-N-(2-hydroxyethoxy)-1-methyl-6-oxo-1,6-dihydropyridazine-3-carboxamide; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals |
08/20/2009 | US20090209540 Novel Biaryl Benzolmidazole Derivatives and Pharmaceutical Composition Comprising The Same |
08/20/2009 | US20090209539 Pyrimidine derivatives as alk-5 Inhibitors |
08/20/2009 | US20090209530 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
08/20/2009 | US20090209528 Substituted tetrahydroisoquinoline compound, their preparation and use in medicaments |
08/20/2009 | US20090209524 Novel Compounds |
08/20/2009 | US20090209519 Pyrimidine compound and pests controlling composition containing the same |
08/20/2009 | US20090209518 Pyrimidine compound and pests controlling composition containing the same |
08/20/2009 | US20090209451 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes |
08/20/2009 | DE102008008838A1 Cycloalkoxy-substituierte 4-Phenyl-3,5-dicyanopyridine und ihre Verwendung Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and their use |
08/20/2009 | CA2714656A1 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and use thereof |
08/20/2009 | CA2714532A1 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
08/20/2009 | CA2714087A1 Inhibitors of checkpoint kinases |
08/20/2009 | CA2713713A1 Piperidine sulfonamide derivatives |
08/20/2009 | CA2713404A1 Pyrimidylmethyl sulfonamide compounds |
08/20/2009 | CA2711757A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
08/19/2009 | EP2090575A1 Processes and intermediates for the preparation of N4-phenyl-quinazoline-4-amine derivatives |
08/19/2009 | EP2090571A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
08/19/2009 | EP2090334A2 Imidazole based compounds, compositions comprising them and methods of their use |
08/19/2009 | EP2089384A2 2-(piperidin-4-yl)-4-phenoxy-or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors |
08/19/2009 | EP2089382A1 Substituted diazepan compounds as orexin receptor antagonists |
08/19/2009 | EP2089381A1 Indoles which act as via receptor antagonists |
08/19/2009 | EP2089380A1 Substituted dihydropyrazolones and use thereof as hif-prolyl-4 -hydroxylase inhibitors |
08/19/2009 | EP2089379A2 A novel crystalline form of lansoprazole |
08/19/2009 | EP2089378A1 Short-acting benzodiazepine salts and their polymorphic forms |
08/19/2009 | EP2089376A1 (r)-phenyl(heterocycle)methanol-based compounds, compositions comprising them and methods of their use |
08/19/2009 | EP2089369A2 2,4 -pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
08/19/2009 | EP2089367A1 Pyrazoline compounds as mineralocorticoid receptor antagonists |
08/19/2009 | EP2089365A1 Heterocyclic derived metalloprotease inhibitors |
08/19/2009 | EP2088860A1 Chemokine receptor binding compounds |
08/19/2009 | EP2035394B1 2-pyrazinecarboxamide derivatives |
08/19/2009 | EP1999113B1 Substituted 1-amino-4-phenyl-dihydroisoquinolines, method for the production thereof, use thereof as a medicament, and medicaments containing them |
08/19/2009 | EP1838304B1 Heterocyclic aspartyl protease inhibitors |
08/19/2009 | EP1718617B1 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators |
08/19/2009 | EP1689712B1 4-phenylpiperidine derivatives as renin inhibitors |
08/19/2009 | EP1685123B1 Substituted dihydroquinazolines ii |
08/19/2009 | EP1590334B1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta |
08/19/2009 | EP1137639B1 Control of arthropods in animals |
08/19/2009 | EP1119356B1 Radiolabeled neurokinin-1 receptor antagonists |
08/19/2009 | CN101511825A Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (GSK3) |
08/19/2009 | CN101511819A N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
08/19/2009 | CN101511818A N-pyridylpiperidine compound, method for producing the same, and pest control agent |
08/19/2009 | CN101511817A Pyridine- and quinoline-pyrimidine-derivatives |
08/19/2009 | CN101511816A An aminoisoquinoline thrombin inhibitor with improved bioavailability |
08/19/2009 | CN101511815A New pyridine analogues |
08/19/2009 | CN101511814A Chemical process |
08/19/2009 | CN101511813A Heterocyclic FXR binding compounds |
08/19/2009 | CN101511812A Pyrazole derivatives as cytochrome P450 inhibitors |